GLP-1 Medication Level Charts: What the Curve Really Shows

A GLP-1 medication level chart in a tracking app is an estimate: a curve calculated from the half-life printed on the drug label and the dose times you logged. It is not a measurement of what is in your blood, and it cannot tell you when or how much to take.

That said, it can be a genuinely useful picture, as long as you know how it is drawn. Think of it like a weather map of a front moving through: helpful for seeing the shape of things, useless for telling you whether it will rain on your exact porch at 3:12 p.m.

How does an app draw a medication level curve?

Most of these charts start from a few numbers published in section 12.3 ("Pharmacokinetics") of the prescribing information. For the two most common weekly injections, the current labels say:

Label fact	Semaglutide injection (Ozempic label)	Tirzepatide (Mounjaro label)
Time to peak after a dose	1 to 3 days	8 to 72 hours
Elimination half-life	About 1 week	About 5 days
Steady state	After 4 to 5 weeks of weekly dosing	After 4 weeks of weekly dosing
Injection site (abdomen, thigh, upper arm)	Similar exposure	Similar exposure

An app takes those averages, picks a simple model (often one where the drug is absorbed and then cleared at a constant rate), and adds up the contribution of every dose you logged. Each dose rises to a peak, then fades by half every half-life. Stack several weeks of doses and you get the familiar sawtooth that slowly climbs and then levels off.

Many apps, GLPily included, show the result as a relative curve rather than a concentration in nanograms per milliliter, because there is no real concentration to show. Nobody drew your blood.

What can the chart actually help with?

Used for what it is, the curve explains things that otherwise feel mysterious:

• Why the first weeks feel different. If a medicine takes four to five weeks of steady weekly dosing to reach steady state, the early weeks are a ramp, not a plateau. That fits with why labels start low and step up.
• Why one late shot does not "reset" everything. With a half-life of about a week, a single dose taken a day late changes the curve a little, not dramatically.
• Why the medicine lingers after stopping. A drug is usually considered mostly cleared after about five half-lives. For a one-week half-life, that is roughly five weeks. Lilly's own medical information says tirzepatide is cleared from the body in about 30 days after the last dose.
• Pattern spotting in your own notes. Some people notice appetite or nausea notes clustering at certain points in the week. Lining those notes up next to the curve can make a pattern easier to describe to your prescriber. (If your appetite seems to come back late in the week, see Appetite Came Back on GLP-1.)

What can't a medication level chart tell you?

This is where precise-looking lines get people into trouble.

It does not know your body. Label half-lives are population averages from clinical pharmacology studies. The semaglutide label itself notes that exposure decreases as body weight increases. Your kidneys, your weight, and plain person-to-person variation all shift the real curve. The app draws the average person who took your logged doses.

It does not know whether a dose made it in. A pen that was not primed per its instructions, a dose that leaked, or a shot you logged but did not take all produce a perfect curve on screen and a different reality in your body.

It cannot say whether the medicine is "working." Weight trend, appetite, side effects, and lab results your clinician orders say far more than a modeled line. A high point on the curve does not mean you should feel full, and a low point does not mean you are "out."

It is not a dosing tool. Do not take an extra dose, take a dose early, or skip one because the curve looks low or high. Timing and missed-dose rules come from the label for your specific product and from your prescriber. We collected what each label says in Missed GLP-1 Dose? What the Label Says.

Why do two apps show different curves for the same dose?

Because they make different choices:

• Absorption speed. The label gives a range (8 to 72 hours for tirzepatide). An app has to pick one point in that range to draw a single line.
• Which half-life. "About 5 days" can become 4.5 or 5.5 in code.
• Scale. Some show percent of peak, some invent a unit, some show steps instead of curves.
• Oral vs injected. Oral semaglutide shares the same molecule and half-life but is absorbed very differently, so it needs its own model.

None of these is necessarily wrong. They are just reminders that the line is an illustration of a model, and models have knobs.

How should a good app present the estimate?

If you are comparing trackers, look for a chart that:

1. Says "estimate" right on the chart, not only in a settings page you will never open.
2. Names its source, such as "typical half-life from the prescribing information."
3. Uses your real log, and updates when you edit a dose or date.
4. Shows no fake units. A number like "4.2 mg in your body" claims a precision nobody has.
5. Never pairs the curve with dose suggestions. No "time for your next shot" based on the curve; reminders should follow the schedule you and your prescriber set.

The eight things to look for in a GLP-1 tracker post covers the rest of the checklist.

How to read your own chart without overthinking it

• Check the inputs first. Wrong date, wrong medicine, or a duplicate entry will bend the curve. Fixing your log matters more than studying the line. Our shot-tracking system keeps entries clean.
• Look at weeks, not hours. The useful information is the shape over a month, not where the line sits this afternoon.
• Bring questions, not conclusions. "My nausea notes cluster on day 2 after the shot. Is that worth adjusting anything?" is a great prescriber question. "My curve says I'm low, so I took more" is not a plan.
• Leave it out of the report unless asked. When you share a tracking report with your clinician, label the curve as an app estimate so nobody mistakes it for a lab value.

If you ever think you injected the wrong amount, do not wait for a chart to tell you anything. Call your prescriber or pharmacist, or Poison Control at 1-800-222-1222. For severe symptoms, call 911.

Common questions

Is the medication level chart in my GLP-1 app accurate?

It is accurate to its model, not to your body. It uses average label values and the doses you entered, so it is a reasonable illustration of the pattern, but it cannot measure your actual drug level.

How long does semaglutide or tirzepatide stay in the body?

The labels list an elimination half-life of about one week for semaglutide and about five days for tirzepatide. Drugs are generally considered mostly cleared after about five half-lives, so roughly five weeks for semaglutide; Lilly says about 30 days for tirzepatide.

Should I time my dose to the curve?

No. Take doses on the schedule your prescriber set and follow your product's label for missed or late doses. Ask your prescriber or pharmacist if anything about timing is unclear.

Why does my chart look different from a friend's?

Different medicines, different dose histories, and different app models all change the line. Even two apps drawing the same log can disagree, because each picks its own absorption speed and scale. Comparing curves between people tells you very little.